Similar articles

• [Difficulties of a clinician in planning psychopharmacological trials (author's transl)].

  Woggon B. Woggon B. Pharmakopsychiatr Neuropsychopharmakol. 1977 May;10(3):140-6. doi: 10.1055/s-0028-1094531. Pharmakopsychiatr Neuropsychopharmakol. 1977. PMID: 360238 Clinical Trial. German.
• Methods and models for placebo use in pharmacotherapeutic trials.

  Prien RF. Prien RF. Psychopharmacol Bull. 1988;24(1):4-8. Psychopharmacol Bull. 1988. PMID: 3290947 Review. No abstract available.
• Placebo effect of psychotropic drugs on patients and staff.

  Galiana M. Galiana M. Rev Neuropsychiatr Infant. 1977 May-Jun;25(5-6):329-33. Rev Neuropsychiatr Infant. 1977. PMID: 331432 Clinical Trial. English. No abstract available.
• [Double-blind cross-over clinical study of a new psychopharmaceutic agent: thiadipone (QM-6008), diazepam and a placebo].

  Conde López V. Conde López V. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1980 Nov-Dec;8(6):409-42. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1980. PMID: 7008536 Clinical Trial. Spanish. No abstract available.
• Placebo in clinical drug trials--a multidisciplinary review.

  Haegerstam G, Huitfeldt B, Nilsson BS, Sjövall J, Syvälahti E, Wahlén A. Haegerstam G, et al. Methods Find Exp Clin Pharmacol. 1982;4(4):261-78. Methods Find Exp Clin Pharmacol. 1982. PMID: 6750286 Review.